These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 30132259

  • 1. Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.
    Bell J, Belackova V, Lintzeris N.
    Drugs; 2018 Sep; 78(13):1339-1352. PubMed ID: 30132259
    [Abstract] [Full Text] [Related]

  • 2. Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia's responses to opioid misuse?
    Belackova V, Salmon AM, Jauncey M, Bell J.
    Int J Drug Policy; 2019 Sep; 71():164-168. PubMed ID: 30975592
    [Abstract] [Full Text] [Related]

  • 3. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N, Groshkova T, Hellier J, Charles V, Martin A, Forzisi L, Lintzeris N, Zador D, Williams H, Carnwath T, Mayet S, Strang J.
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S, Barrett B, Metrebian N, Groshkova T, Cary M, Charles V, Lintzeris N, Strang J.
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [Abstract] [Full Text] [Related]

  • 6. Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.
    Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT.
    BMC Health Serv Res; 2011 Jul 26; 11():174. PubMed ID: 21791093
    [Abstract] [Full Text] [Related]

  • 7. Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.
    Rodgers C, Siefried KJ, Ritter A, Belackova V, Treloar C, Jauncey M, Ezard N, Roberts D, Steele M, van den Brink W, Strang J, Oviedo-Joekes E, Lintzeris N, Dunlop AJ, Bell J.
    BMJ Open; 2024 Aug 03; 14(8):e082553. PubMed ID: 39097309
    [Abstract] [Full Text] [Related]

  • 8. Slow-release oral morphine as maintenance therapy for opioid dependence.
    Ferri M, Minozzi S, Bo A, Amato L.
    Cochrane Database Syst Rev; 2013 Jun 05; (6):CD009879. PubMed ID: 23740540
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial.
    Marsden J, Stillwell G, Hellier J, Brown AM, Byford S, Kelleher M, Kelly J, Murphy C, Shearer J, Mitcheson L.
    Contemp Clin Trials; 2017 Feb 05; 53():36-43. PubMed ID: 27940188
    [Abstract] [Full Text] [Related]

  • 10. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, Somaini L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):483-9. PubMed ID: 21147192
    [Abstract] [Full Text] [Related]

  • 11. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
    Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.
    Subst Abuse Treat Prev Policy; 2017 May 19; 12(1):25. PubMed ID: 28526048
    [Abstract] [Full Text] [Related]

  • 12. Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.
    Oviedo-Joekes E, Brissette S, MacDonald S, Guh D, Marchand K, Jutha S, Harrison S, Janmohamed A, Zhang DZ, Anis AH, Krausz M, Marsh DC, Schechter MT.
    Drug Alcohol Depend; 2017 Jul 01; 176():55-62. PubMed ID: 28521199
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
    Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, Stewart D, Welch S.
    Addiction; 2000 Nov 01; 95(11):1631-45. PubMed ID: 11219367
    [Abstract] [Full Text] [Related]

  • 14. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review.
    McNair R, Monaghan M, Montgomery P.
    Drug Alcohol Depend; 2023 Jun 01; 247():109869. PubMed ID: 37086659
    [Abstract] [Full Text] [Related]

  • 15. Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.
    Fairbairn N, Ross J, Trew M, Meador K, Turnbull J, MacDonald S, Oviedo-Joekes E, Le Foll B, Goyer MÈ, Perreault M, Sutherland C.
    CMAJ; 2019 Sep 23; 191(38):E1049-E1056. PubMed ID: 31548191
    [No Abstract] [Full Text] [Related]

  • 16. Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series.
    Vogel M, Köck P, Strasser J, Kalbermatten C, Binder H, Dürsteler KM, Walter M, Falcato L, Krausz M, Kormann A.
    Eur Addict Res; 2022 Sep 23; 28(1):80-86. PubMed ID: 34311466
    [Abstract] [Full Text] [Related]

  • 17. Short term health-related quality of life improvement during opioid agonist treatment.
    Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, Potter J, Ang A, Hser YI, Ling W, Schackman BR.
    Drug Alcohol Depend; 2015 Dec 01; 157():121-8. PubMed ID: 26511766
    [Abstract] [Full Text] [Related]

  • 18. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.
    Groshkova T, Metrebian N, Hallam C, Charles V, Martin A, Forzisi L, Lintzeris N, Strang J.
    Drug Alcohol Rev; 2013 Nov 01; 32(6):566-73. PubMed ID: 24118500
    [Abstract] [Full Text] [Related]

  • 19. Painkillers fuel growth in drug addiction. Opioid overdoses now kill more people than cocaine or heroin.
    Harv Ment Health Lett; 2011 Jan 01; 27(7):4-5. PubMed ID: 21322902
    [No Abstract] [Full Text] [Related]

  • 20. Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities.
    Friedmann Z, Kinkel HT, Kühner C, Zsolnai A, Binder A, Mick I.
    Addict Sci Clin Pract; 2024 May 27; 19(1):45. PubMed ID: 38802962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.